{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:52:55Z","timestamp":1790502775634,"version":"4.1.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2020.00095","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T09:01:20Z","timestamp":1591866080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Caroline","family":"Mullis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia H.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":"Persistent immune activation in HIV-1 infection is associated with progression to AIDS","volume":"17","author":"Hazenberg","year":"2003","journal-title":"AIDS."},{"key":"B3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1743-422X-9-174","article-title":"The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review","volume":"9","author":"Vassallo","year":"2012","journal-title":"Virol J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis."},{"key":"B7","first-page":"101","article-title":"Aging, inflammation, and HIV infection","volume":"20","author":"Aberg","year":"2012","journal-title":"Top Antivir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/infdis\/jir507","article-title":"Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells","volume":"204","author":"Lederman","year":"2011","journal-title":"J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","article-title":"CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART","volume":"24","author":"Massanella","year":"2010","journal-title":"AIDS."},{"key":"B12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/COH.0000000000000230","article-title":"Residual inflammation and viral reservoirs: alliance against an HIV cure","volume":"11","author":"Massanella","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ni1316","article-title":"HIV disease: fallout from a mucosal catastrophe?","volume":"7","author":"Brenchley","year":"2006","journal-title":"Nat Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"J Exp Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","article-title":"Dissecting how CD4 T cells are lost during HIV infection","volume":"19","author":"Doitsh","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature22066","article-title":"Corrigendum: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"544","author":"Doitsh","year":"2017","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","article-title":"Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells","volume":"12","author":"Galloway","year":"2015","journal-title":"Cell Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1243640","article-title":"IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV","volume":"343","author":"Monroe","year":"2014","journal-title":"Science."},{"key":"B24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2015.09.010","article-title":"Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection","volume":"18","author":"Mu\u00f1oz-Arias","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the american heart association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/infdis\/jiz256","article-title":"The role of inflammation in HIV-associated atherosclerosis - one size may not fit all","volume":"221","author":"Currier","year":"2019","journal-title":"J Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jacc.2016.09.979","article-title":"HIV and ischemic heart disease","volume":"69","author":"Vachiat","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"ofv108","DOI":"10.1093\/ofid\/ofv108","article-title":"Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population","volume":"2","author":"Hasse","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cjca.2018.11.029","article-title":"Coronary artery disease manifestations in HIV: what, how, and why","volume":"35","author":"Sinha","year":"2019","journal-title":"Can J Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","article-title":"Time to recognize HIV infection as a major cardiovascular risk factor","volume":"138","author":"Hsue","year":"2018","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11904-013-0168-6","article-title":"Cardiovascular disease and HIV infection","volume":"10","author":"Triant","year":"2013","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833a0918","article-title":"Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study","volume":"24","author":"Smith","year":"2010","journal-title":"AIDS."},{"key":"B34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","article-title":"Serious fatal and nonfatal non-AIDS-defining illnesses in Europe","volume":"55","author":"Mocroft","year":"2010","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000001554","article-title":"Inflammation-related morbidity and mortality among HIV-positive adults: how extensive is it?","volume":"77","author":"Hart","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e000844","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"Nordell","year":"2014","journal-title":"J Am Heart Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e000174","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open Heart."},{"key":"B41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"key":"B43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/138920112798868520","article-title":"HIV and accelerated atheroprogression: role of antiretroviral therapy","volume":"13","author":"Di Biagio","year":"2012","journal-title":"Curr Pharm Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","article-title":"Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors","volume":"162","author":"Seminari","year":"2002","journal-title":"Atherosclerosis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00126334-200304150-00004","article-title":"Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients","volume":"32","author":"Chironi","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/j.semdp.2017.04.002","article-title":"Aging with HIV in the ART era","volume":"34","author":"Kaplan-Lewis","year":"2017","journal-title":"Semin Diagn Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamacardio.2016.5139","article-title":"Types of myocardial infarction among human immunodeficiency virus-infected individuals in the United States","volume":"2","author":"Crane","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B48","first-page":"127","article-title":"Cardiovascular complications of HIV infection","volume":"24","author":"Glesby","year":"2017","journal-title":"Top Antivir Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.4049\/jimmunol.1502203","article-title":"Aberrant inflammasome activation characterizes tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"196","author":"Tan","year":"2016","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1016\/0197-2456(91)90002-4","article-title":"Cardiovascular risk factors in young adults. the CARDIA baseline monograph","volume":"12","author":"Cutter","year":"1991","journal-title":"Control Clin Trials."},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11904-014-0247-3","article-title":"Understanding frailty, aging, and inflammation in HIV infection","volume":"12","author":"Leng","year":"2015","journal-title":"Curr HIV AIDS Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy","volume":"106","author":"Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B57","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/infdis\/jiq138","article-title":"A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response","volume":"203","author":"Hatano","year":"2011","journal-title":"J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/COH.0000000000000434","article-title":"The microbiome and HIV persistence: implications for viral remission and cure","volume":"13","author":"Koay","year":"2018","journal-title":"Curr Opin HIV AIDS."},{"key":"B59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2016.4728","article-title":"Association of arterial and lymph node inflammation with distinct inflammatory pathways in human immunodeficiency virus infection","volume":"2","author":"Tawakol","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s40506-018-0158-8","article-title":"Current treatment options for HIV elite controllers: a review","volume":"10","author":"Promer","year":"2018","journal-title":"Curr Treat Options Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/2047487312447843","article-title":"HIV infection and atherosclerosis: evaluating the drivers of inflammation","volume":"20","author":"Maniar","year":"2013","journal-title":"Eur J Prev Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/ATVBAHA.113.302191","article-title":"HIV, inflammation, and calcium in atherosclerosis","volume":"34","author":"Shrestha","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1097\/QAD.0000000000001149","article-title":"Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy","volume":"30","author":"Hsu","year":"2016","journal-title":"AIDS."},{"key":"B64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11908-010-0153-9","article-title":"Inflammatory markers associated with coronary heart disease in persons with HIV infection","volume":"13","author":"Fichtenbaum","year":"2011","journal-title":"Curr Infect Dis Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e014873","DOI":"10.1161\/JAHA.119.014873","article-title":"Targeting inflammation to reduce atherosclerotic cardiovascular risk in people with HIV infection","volume":"9","author":"Titanji","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B66","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1093\/infdis\/jiw288","article-title":"Cardiovascular disease, statins, and HIV","volume":"214","author":"Eckard","year":"2016","journal-title":"J Infect Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/cid\/cit748","article-title":"Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"58","author":"Funderburg","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"ofw278","DOI":"10.1093\/ofid\/ofw278","article-title":"A randomized placebo controlled trial of aspirin effects on immune activation in chronically human immunodeficiency virus-infected adults on virologically suppressive antiretroviral therapy","volume":"4","author":"O'Brien","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/QAD.0000000000000830","article-title":"Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy","volume":"29","author":"Nasi","year":"2015","journal-title":"AIDS."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1004082","DOI":"10.1371\/journal.ppat.1004082","article-title":"HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon","volume":"10","author":"Chattergoon","year":"2014","journal-title":"PLoS Pathog."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2015.00585","article-title":"Purinergic receptors: key mediators of HIV-1 infection and inflammation","volume":"6","author":"Swartz","year":"2015","journal-title":"Front Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fimmu.2018.00214","article-title":"The NLRP3 inflammasome is upregulated in HIV-infected antiretroviral therapy-treated individuals with Defective Immune Recovery","volume":"9","author":"Bandera","year":"2018","journal-title":"Front Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2019.12.001","article-title":"Inflammasome in HIV infection: lights and shadows","volume":"118","author":"Leal","year":"2020","journal-title":"Mol Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000353902","article-title":"HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages","volume":"57","author":"Hernandez","year":"2014","journal-title":"Intervirology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"21716","DOI":"10.1074\/jbc.M114.566620","article-title":"HIV-1 infection induces interleukin-1beta production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes","volume":"289","author":"Guo","year":"2014","journal-title":"J Biol Chem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1128\/JVI.02297-15","article-title":"Next-generation mRNA sequencing reveals pyroptosis-induced CD4+ T cell death in early simian immunodeficiency virus-infected lymphoid tissues","volume":"90","author":"Lu","year":"2016","journal-title":"J Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/aid.2016.0234","article-title":"Caspase-1 activity in CD4 T cells is downregulated following antiretroviral therapy for HIV-1 infection","volume":"33","author":"Cai","year":"2017","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0192845","DOI":"10.1371\/journal.pone.0192845","article-title":"HIV replication is associated to inflammasomes activation, IL-1\u03b2, IL-18 and caspase-1 expression in GALT and peripheral blood","volume":"13","author":"Feria","year":"2018","journal-title":"PLoS ONE."},{"key":"B82","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/QAD.0000000000001693","article-title":"Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients","volume":"32","author":"Ahmad","year":"2018","journal-title":"AIDS."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0121011","DOI":"10.1371\/journal.pone.0121011","article-title":"Longitudinal changes in plasma caspase-1 and caspase-3 during the first 2 years of HIV-1 infection in CD4Low and CD4High patient groups","volume":"10","author":"Song","year":"2015","journal-title":"PLoS ONE."},{"key":"B84","doi-asserted-by":"publisher","first-page":"27864","DOI":"10.1038\/srep27864","article-title":"Effect of cocaine on HIV infection and inflammasome gene expression profile in HIV infected macrophages","volume":"6","author":"Atluri","year":"2016","journal-title":"Sci Rep."},{"key":"B85","first-page":"165","article-title":"Inflammasome in drug abuse","volume":"9","author":"Xu","year":"2017","journal-title":"Int J Physiol Pathophysiol Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0155076","DOI":"10.1371\/journal.pone.0155076","article-title":"Activation of cannabinoid receptor 2 ameliorates DSS-induced colitis through inhibiting NLRP3 inflammasome in macrophages","volume":"11","author":"Ke","year":"2016","journal-title":"PLoS ONE."},{"key":"B87","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10753-018-0945-x","article-title":"Selective activation of cannabinoid receptor 2 attenuates myocardial infarction via suppressing NLRP3 inflammasome","volume":"42","author":"Yu","year":"2019","journal-title":"Inflammation."},{"key":"B88","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/MOL.0b013e328359b0a6","article-title":"Effect of interleukin 1\u03b2 inhibition in cardiovascular disease","volume":"23","author":"Qamar","year":"2012","journal-title":"Curr Opin Lipidol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/icb.2014.5","article-title":"Caspases and inflammasomes in metabolic inflammation","volume":"92","author":"Skeldon","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/archinte.163.17.2006","article-title":"An update on aspirin in the primary prevention of cardiovascular disease","volume":"163","author":"Eidelman","year":"2003","journal-title":"Arch Intern Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/infdis\/jiz344","article-title":"A randomized, placebo-controlled, pilot clinical trial of dipyridamole to decrease Hiv-associated chronic inflammation","volume":"221","author":"Macatangay","year":"2019","journal-title":"J Infect Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"ofaa026","DOI":"10.1093\/ofid\/ofaa026","article-title":"Factor Xa inhibition reduces coagulation activity but not inflammation among people with HIV: a randomized clinical trial","volume":"7","author":"Baker","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10557-012-6411-3","article-title":"The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis","volume":"26","author":"Kadoglou","year":"2012","journal-title":"Cardiovasc Drugs Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/jpet.112.194837","article-title":"The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice","volume":"343","author":"Lee","year":"2012","journal-title":"J Pharmacol Exp Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/cid\/ciy781","article-title":"Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS clinical trials group study A5314","volume":"68","author":"Hsue","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1161\/ATVBAHA.118.311807","article-title":"Brachial artery echogenicity and grayscale texture changes in HIV-infected individuals receiving low-dose methotrexate","volume":"38","author":"Stein","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"Funderburg","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV."},{"key":"B101","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/ATVBAHA.116.308963","article-title":"Prevention of diet-induced metabolic dysregulation, inflammation, and atherosclerosis in","volume":"37","author":"Samsoondar","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.2019.16598","article-title":"Bempedoic acid for lowering LDL cholesterol","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1001\/jama.2019.16585","article-title":"Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR wisdom randomized clinical trial","volume":"322","author":"Goldberg","year":"2019","journal-title":"JAMA."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.jacc.2018.09.038","article-title":"IL-1\u03b2 inhibition reduces atherosclerotic inflammation in HIV infection","volume":"72","author":"Hsue","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8722-7-10","article-title":"Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases","volume":"7","author":"Nagao","year":"2014","journal-title":"J Hematol Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-019-1565-6","article-title":"Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro","volume":"16","author":"Gavegnano","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/hrt.2009.168971","article-title":"Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis","volume":"95","author":"Ikonomidis","year":"2009","journal-title":"Heart."},{"key":"B109","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/v9040064","article-title":"Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs","volume":"9","author":"Pasquereau","year":"2017","journal-title":"Viruses"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/iid3.160","article-title":"Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients","volume":"5","author":"d'Ettorre","year":"2017","journal-title":"Immun Inflamm Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e0137200","DOI":"10.1371\/journal.pone.0137200","article-title":"Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the \u201cProbio-HIV\u201d clinical trial","volume":"10","author":"d'Ettorre","year":"2015","journal-title":"PLoS ONE."},{"key":"B113","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiu515","article-title":"Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286","volume":"211","author":"Tenorio","year":"2015","journal-title":"J Infect Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cjca.2011.10.013","article-title":"Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice","volume":"28","author":"Gage","year":"2012","journal-title":"Can J Cardiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2012.07.058","article-title":"Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice","volume":"425","author":"Usui","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1111\/febs.13279","article-title":"Bone marrow-specific caspase-1\/11 deficiency inhibits atherosclerosis development in Ldlr(-\/-) mice","volume":"282","author":"Hendrikx","year":"2015","journal-title":"FEBS J."},{"key":"B117","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.107.746453","article-title":"Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice","volume":"117","author":"Yajima","year":"2008","journal-title":"Circulation."},{"key":"B118","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","article-title":"Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases","volume":"113","author":"Liu","year":"2017","journal-title":"Basic Res Cardiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation."},{"key":"B120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2016.11.017","article-title":"Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome","volume":"481","author":"Sun","year":"2016","journal-title":"Biochem Biophys Res Commun."},{"key":"B121","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/cvr\/cvu114","article-title":"LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis","volume":"103","author":"Ding","year":"2014","journal-title":"Cardiovasc Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.201041316","article-title":"Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis","volume":"41","author":"Freigang","year":"2011","journal-title":"Eur J Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2018.03.018","article-title":"Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns","volume":"131","author":"Pavillard","year":"2018","journal-title":"Pharmacol Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biocel.2017.01.001","article-title":"Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)\/thioredoxin-interacting protein (TXNIP) pathway","volume":"84","author":"Yin","year":"2017","journal-title":"Int J Biochem Cell Biol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00109-014-1144-3","article-title":"The role of the inflammasome in cardiovascular diseases","volume":"92","author":"Li","year":"2014","journal-title":"J Mol Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","article-title":"IL-1beta and IL-18: inflammatory markers or mediators of hypertension?","volume":"171","author":"Krishnan","year":"2014","journal-title":"Br J Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M062828","article-title":"Suppression of NLRP3 inflammasome by gamma-tocotrienol ameliorates type 2 diabetes","volume":"57","author":"Kim","year":"2016","journal-title":"J Lipid Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","article-title":"Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model","volume":"28","author":"Luo","year":"2014","journal-title":"Cardiovasc Drugs Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12012-015-9344-9","article-title":"NF-kappaB blockade in hypothalamic paraventricular nucleus inhibits high-salt-induced hypertension through NLRP3 and caspase-1","volume":"16","author":"Qi","year":"2016","journal-title":"Cardiovasc Toxicol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbadis.2017.10.001","article-title":"The SGK1 inhibitor EMD638683, prevents angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation","volume":"1864","author":"Gan","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.apcsb.2017.02.002","article-title":"Stress-induced NLRP3 inflammasome in human diseases","volume":"108","author":"Alcocer-Gomez","year":"2017","journal-title":"Adv Protein Chem Struct Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem Biophys Res Commun."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]","volume":"111","author":"Abbate","year":"2013","journal-title":"Am J Cardiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/eurjhf\/hfq017","article-title":"Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse","volume":"12","author":"Abbate","year":"2010","journal-title":"Eur J Heart Fail."},{"key":"B136","doi-asserted-by":"publisher","first-page":"91291","DOI":"10.18632\/oncotarget.20443","article-title":"Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation."},{"key":"B139","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fcvm.2018.00062","article-title":"Antiinflammatory therapy in clinical care: the CANTOS trial and beyond","volume":"5","author":"Aday","year":"2018","journal-title":"Front Cardiovasc Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS","volume":"75","author":"Rothman","year":"2020","journal-title":"Hypertension."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.07.007","article-title":"Immunotherapy for the prevention of atherosclerotic cardiovascular disease: promise and possibilities","volume":"276","author":"Khambhati","year":"2018","journal-title":"Atherosclerosis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","article-title":"Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice","volume":"24","author":"Gomez","year":"2018","journal-title":"Nat Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.117.033254","article-title":"Mortality differences associated with treatment responses in CANTOS and FOURIER: insights and implications","volume":"137","author":"Ridker","year":"2018","journal-title":"Circulation."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","author":"Ridker","year":"2019","journal-title":"Eur Heart J."},{"key":"B147","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcvm.2019.00016","article-title":"Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease","volume":"6","author":"Aday","year":"2019","journal-title":"Front Cardiovasc Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1074248418778548","article-title":"The utility of anti-inflammatory agents in cardiovascular disease: a novel perspective on the treatment of atherosclerosis","volume":"23","author":"Kottoor","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B149","doi-asserted-by":"publisher","first-page":"111847","DOI":"10.1016\/j.yexcr.2020.111847","article-title":"VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis","volume":"389","author":"Li","year":"2020","journal-title":"Exp Cell Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","article-title":"HIV-1-associated atherosclerosis: unraveling the missing link","volume":"69","author":"Kearns","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/ATVBAHA.119.312603","article-title":"Caspase-1 activation is related with HIV-associated atherosclerosis in an HIV transgenic mouse model and HIV patient cohort","volume":"39","author":"Kearns","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/labinvest.2009.29","article-title":"Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat\/high-cholesterol diet","volume":"89","author":"Yearley","year":"2009","journal-title":"Lab Invest."},{"key":"B153","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/infdis\/jiz253","article-title":"Soluble markers of interleukin 1 activation as predictors of first-time myocardial infarction in HIV-infected individuals","volume":"221","author":"Hoel","year":"2020","journal-title":"J Infect Dis."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T18:40:13Z","timestamp":1616179213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":153,"alternative-id":["10.3389\/fcvm.2020.00095"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.00095","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"article-number":"95"}}